Spark Therapeutics’ ground-breaking gene therapy now being administered at select hospitals – Philadelphia Business Journal
|
Spark Therapeutics' ground-breaking gene therapy now being administered at select hospitals
Philadelphia Business Journal Spark Therapeutics' ground-breaking gene therapy Luxturna is now being used to treat patients with a rare, inherited eye condition at a small group of medical centers across the country. “The intent behind any innovation in the lab is to ensure that … |
